Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 672 entries
View as:

Safety Study of Once a Day ART and Opiate Substitute.

Phase: N/A Priority: Normal
NCT ID: NCT00324688 Org: User:
Start: 03/31/03 End: 06/30/06 Due: 06/30/07

Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01452308 Org: User:
Start: 11/30/11 End: 08/31/13 Due: 08/31/14

Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01270698 Org: User:
Start: 05/31/11 End: 12/31/14 Due: 12/31/15

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT01282424 Org: User:
Start: 03/18/11 End: 05/16/18 Due: 05/16/19

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00002219 Org: User:
Start: - End: - Due: -

DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00330369 Org: User:
Start: 06/30/06 End: 01/31/09 Due: 01/31/10

Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways

Phase: N/A Priority: Normal
NCT ID: NCT01404234 Org: User:
Start: 12/31/11 End: 04/30/13 Due: 04/30/14

Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen

Phase: N/A Priority: Normal
NCT ID: NCT02285114 Org: User:
Start: 01/20/15 End: 12/11/24 Due: 12/11/25

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06290934 Org: User:
Start: 03/27/24 End: 02/28/27 Due: 02/28/28

Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT06585150 Org: User:
Start: 10/14/24 End: 06/09/25 Due: 06/09/26

Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

Phase: N/A Priority: Normal
NCT ID: NCT01687257 Org: User:
Start: 07/31/12 End: 10/31/15 Due: 10/31/16

A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication

Phase: N/A Priority: Normal
NCT ID: NCT01865786 Org: User:
Start: 01/01/13 End: 03/13/18 Due: 03/13/19

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Phase: N/A Priority: Normal
NCT ID: NCT05633654 Org: User:
Start: 12/12/22 End: 08/31/31 Due: 08/31/32

Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil

Phase: N/A Priority: Normal
NCT ID: NCT00307489 Org: User:
Start: 03/31/06 End: 10/31/10 Due: 10/31/11

Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine

Phase: N/A Priority: Normal
NCT ID: NCT00743340 Org: User:
Start: 11/22/05 End: 02/13/17 Due: 02/13/18

Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT03036852 Org: User:
Start: 03/22/17 End: 11/07/18 Due: 11/07/19

Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02479880 Org: User:
Start: 07/03/15 End: 04/11/18 Due: 04/11/19

Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT02759562 Org: User:
Start: 11/04/16 End: 07/21/17 Due: 07/21/18

Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT01797445 Org: User:
Start: 03/12/13 End: 10/03/18 Due: 10/03/19

Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01494987 Org: User:
Start: 01/31/12 End: 08/31/13 Due: 08/31/14

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT00091598 Org: User:
Start: 01/31/04 End: 02/28/06 Due: 02/28/07

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01371578 Org: User:
Start: 07/31/11 End: 03/31/13 Due: 03/31/14

GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

Phase: N/A Priority: Normal
NCT ID: NCT01384383 Org: User:
Start: 08/31/11 End: 06/30/13 Due: 06/30/14

Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

Phase: N/A Priority: Normal
NCT ID: NCT02016924 Org: User:
Start: 01/16/14 End: 03/31/27 Due: 03/31/28

Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00365612 Org: User:
Start: 07/31/06 End: 01/31/08 Due: 01/31/09